Christian B. Voigtlander Sells 4,985 Shares of ICU Medical, Inc. (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) COO Christian B. Voigtlander sold 4,985 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $128.50, for a total transaction of $640,572.50. Following the sale, the chief operating officer now owns 6,088 shares of the company's stock, valued at $782,308. This trade represents a 45.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

ICU Medical Stock Performance

NASDAQ ICUI traded down $2.73 during trading on Wednesday, hitting $127.72. 55,063 shares of the company's stock traded hands, compared to its average volume of 276,698. ICU Medical, Inc. has a 12-month low of $100.91 and a 12-month high of $196.26. The business has a 50 day moving average of $138.87 and a 200-day moving average of $151.88. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of -27.95 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. The company had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. ICU Medical's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.96 EPS. As a group, equities research analysts anticipate that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Institutional Trading of ICU Medical

Institutional investors have recently added to or reduced their stakes in the business. Intech Investment Management LLC raised its stake in shares of ICU Medical by 38.6% in the first quarter. Intech Investment Management LLC now owns 11,938 shares of the medical instruments supplier's stock worth $1,658,000 after buying an additional 3,326 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in ICU Medical by 32.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 68,211 shares of the medical instruments supplier's stock valued at $9,472,000 after buying an additional 16,680 shares during the period. Woodline Partners LP lifted its holdings in shares of ICU Medical by 31.6% in the 1st quarter. Woodline Partners LP now owns 160,910 shares of the medical instruments supplier's stock worth $22,344,000 after acquiring an additional 38,671 shares during the last quarter. United Services Automobile Association bought a new position in shares of ICU Medical during the first quarter valued at approximately $218,000. Finally, Dynamic Technology Lab Private Ltd increased its stake in ICU Medical by 855.9% in the first quarter. Dynamic Technology Lab Private Ltd now owns 12,427 shares of the medical instruments supplier's stock worth $1,726,000 after purchasing an additional 11,127 shares during the period. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ICUI shares. Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday, May 18th. Raymond James reduced their price target on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research report on Friday, May 9th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, KeyCorp dropped their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $192.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.